Rye, NY, United States of America

Aaron Alain-Jon Golden

This inventor holds 1 USPTO granted patent. Top assignee: Albert Einstein College of Medicine. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron Alain-Jon Golden. Retrieved from https://idiyas.com/inventor/aaron-alain-jon-golden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Aaron Alain-Jon Golden

Introduction

Aaron Alain-Jon Golden is a notable inventor based in Rye, NY (US). He has made significant contributions to the field of medical science, particularly in the area of radiation exposure and treatment. His work is characterized by a commitment to advancing healthcare through innovative solutions.

Latest Patents

Aaron Golden holds a patent titled "Host and intestinal microbiota derived metabolomic blood plasma signature for prior radiation injury." This patent provides methods for determining prior radiation dose exposure levels for subjects, along with kits designed for this purpose. Additionally, it outlines methods of treatment for individuals affected by radiation exposure. He has 1 patent to his name.

Career Highlights

Aaron Golden is affiliated with the Albert Einstein College of Medicine, where he contributes to research and development in his field. His work at this esteemed institution underscores his dedication to improving medical outcomes for patients exposed to radiation.

Collaborations

Throughout his career, Aaron has collaborated with esteemed colleagues, including Pilib Ó Broin and Chandan Guha. These partnerships have enhanced the scope and impact of his research.

Conclusion

Aaron Alain-Jon Golden exemplifies the spirit of innovation in medical science through his patent and collaborative efforts. His work continues to pave the way for advancements in understanding and treating radiation exposure.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…